Roger Williams Medical Center

Summary

Roger Williams Medical Center is a medical facility located in Providence, Rhode Island. This center is recognized for care of Breast Cancer, Lung Cancer, Pancreatic Cancer, HIV Infection, Human Immunodeficiency Virus Infection and other specialties. Roger Williams Medical Center is involved with conducting 100 clinical trials across 148 conditions. There are 2 research doctors associated with this hospital, such as Ritesh Rathore and Sung Kwon.

Top PIs

Clinical Trials running at Roger Williams Medical Center

Ovarian Cancer

Lung Cancer

Cancer

Breast Cancer

Fallopian Tube Cancer

Breast cancer

Leukemia

Non-Small Cell Lung Cancer

Multiple Myeloma

Prostate Cancer

Biobank Collection

for Cancer

This trial collects multiple tissue and blood samples, along with medical information, from cancer patients. The "Cancer Moonshot Biobank" is a longitudinal study. This means it collects and stores samples and information over time, throughout the course of a patient's cancer treatment. By looking at samples and information collected from the same people over time, researchers hope to better understand how cancer changes over time and over the course of medical treatments.

Recruiting

1 award

N/A

10 criteria

Targeted Therapy

for Solid Tumors

This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally advanced) or have spread to other places in the body (advanced) and have progressed on at least one line of standard systemic therapy or have no standard treatment that has been shown to prolong overall survival may be candidates for these trials. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with some genetic changes or abnormalities (mutations) may benefit from treatment that targets that particular genetic mutation. ComboMATCH is designed to match patients to a treatment that may work to control their tumor and may help doctors plan better treatment for patients with locally advanced or advanced solid tumors.

Recruiting

1 award

Phase 2

17 criteria